(Q39091679)

9 September 2017

title

A role for paralog-specific sumoylation in histone deacetylase 1 stability (English)

1 reference

9 September 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Christian Seiser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Simona Citro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Ellis Jaffray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Susanna Chiocca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

25 September 2013

1 reference

Journal of Molecular Cell Biology

9 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

416-427

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068740%20AND%20SRC:MED&resulttype=core&format=json

The development of proteasome inhibitors as anticancer drugs

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

A mechanism for inhibiting the SUMO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Sumo paralogs: redundancy and divergencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Substantially reduced expression of PIAS1 is associated with colon cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Ubch9 conjugates SUMO but not ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Concepts in sumoylation: a decade on

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

An additional role for SUMO in ubiquitin-mediated proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Something about SUMO inhibits transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Signalling pathways and the regulation of SUMO modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Proteasome inhibitors: an expanding army attacking a unique target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Histone deacetylase 2 (HDAC2) regulates chromosome segregation and kinetochore function via H4K16 deacetylation during oocyte maturation in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

PARP-1 transcriptional activity is regulated by sumoylation upon heat shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Getting into position: the catalytic mechanisms of protein ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

HDAC inhibitors for the treatment of cutaneous T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Role for histone deacetylase 1 in human tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

HDAC expression and clinical prognosis in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

A recurrent phospho-sumoyl switch in transcriptional repression and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

HDAC6 expression is correlated with better survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032

How accurate are cancer cell lines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJMCB%2FMJT032